Capital Research Global Investors
Capital Research Global Investors reported 422 stocks worth $704B in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are MSFT (6.9%), NVDA (6.9%) and AVGO (5.4%). Compared with Q2 2026, the fund opened new positions in XOM, added to NVDA, META and PM, trimmed AVGO, AMZN and GOOGL and sold out of XOM, LRCX and HONA.
Latest filing: what Capital Research Global Investors did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() MSFT Microsoft Corp | $48.6B | 6.9% | 94.7M | No change | 8 of 8 | |
| 2 | ![]() NVDA Nvidia Corporation | $48.5B | 6.9% | 212M | +9.5M (+5%) | 8 of 8 | |
| 3 | ![]() AVGO Broadcom Inc | $38.2B | 5.4% | 109M | −4.4M (−4%) | 8 of 8 | |
| 4 | ![]() META Meta Platforms Inc | $31.2B | 4.4% | 43M | +3.4M (+9%) | 8 of 8 | |
| 5 | ![]() AMZN Amazon Com Inc | $29.4B | 4.2% | 118M | −2.6M (−2%) | 8 of 8 | |
| 6 | ![]() GOOGL Alphabet Inc | $21B | 3.0% | 60.9M | −1.6M (−3%) | 8 of 8 | |
| 7 | ![]() LLY Eli Lilly & Co | $19.7B | 2.8% | 17M | −3.9M (−19%) | 8 of 8 | |
| 8 | ![]() AAPL Apple Inc | $16.5B | 2.3% | 49.6M | −9.8M (−17%) | 8 of 8 | |
| 9 | ![]() PM Philip Morris Intl Inc | $16.3B | 2.3% | 85.6M | +1.4M (+2%) | 8 of 8 | |
| 10 | ![]() GOOG Alphabet Inc | $13.3B | 1.9% | 39M | −3.9M (−9%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() XOM Exxon Mobil Corp | $4.6B | 33.3M |
![]() LRCX Lam Research Corp | $738M | 1.7M |
![]() HONA Honeywell Aerospace Inc Com | $730M | 3.3M |
![]() AMD Advanced Micro Devices Inc | $630M | 1.1M |
TOPBUILD CORP | $554M | 1.6M |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 12, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Capital Research Global Investors 13F FAQ
What does Capital Research Global Investors own?
Capital Research Global Investors reported 422 stocks worth $704B in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are MSFT (6.9%), NVDA (6.9%) and AVGO (5.4%). The table above lists every position in the filing (the top 10 without an account).
What did Capital Research Global Investors buy and sell in Q3 2026?
Compared with Q2 2026: 45 new positions, 179 added to, 161 trimmed and 47 sold out. New positions include XOM. It sold all of XOM, LRCX and HONA.
When will Capital Research Global Investors file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Capital Research Global Investors's portfolio worth?
The Q3 2026 filing reports $704B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.



















